BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//European Brain Council (EBC) - ECPv6.15.19//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.braincouncil.eu
X-WR-CALDESC:Events for European Brain Council (EBC)
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Moscow
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0300
TZNAME:MSK
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240419
DTEND;VALUE=DATE:20240421
DTSTAMP:20260415T194746
CREATED:20240325T094916Z
LAST-MODIFIED:20240326T140324Z
UID:53708-1713484800-1713657599@www.braincouncil.eu
SUMMARY:EMSP Annual Conference 2024
DESCRIPTION:Multiple Sclerosis – toward sustainable and healthier systems in EuropeEMSP Annual Conference 2024 with the theme of Multiple Sclerosis – toward sustainable and healthier systems in Europe\, will take place between 19-20 April 2024 in Thon Hotel EU (Rue de la Loi 75) in Brussels\, Belgium. \nAs part of a programme\, Frédéric Destrebecq\, EBC Executive Director will hold a session on 19 April at 15:45 on the topic “Commitment to MS and other related rare conditions cure: Advancing research in Europe”. \nHeld as an in-person event co-hosted by the Belgian Society\, the conference will offer the latest Multiple Sclerosis developments\, expert insights\, and networking with the community. \nRead more about the eventRegister here
URL:https://www.braincouncil.eu/event/emsp-annual-conference-2024/
LOCATION:Brussels\, Belgium
ATTACH;FMTTYPE=image/webp:https://www.braincouncil.eu/wp-content/uploads/2024/03/734ebf865ab84e378eba86c63f503337_511529c11819d466f9c80578c0a69287.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240424
DTEND;VALUE=DATE:20240427
DTSTAMP:20260415T194746
CREATED:20240103T135316Z
LAST-MODIFIED:20240313T123741Z
UID:51279-1713916800-1714175999@www.braincouncil.eu
SUMMARY:36th Global Conference of Alzheimer’s Disease International
DESCRIPTION:The 36th Global Conference of Alzheimer’s Disease International will take place in Kraków\, Poland from 24-26 April 2024\, with ADI member Polskie Stowarzyszenie Pomocy Osobom z Chorobą Alzheimera (Polish Alzheimer’s Association). \nComing together under the conference theme of ‘Dementia: Insights. Innovations. Inspirations.’\, the conference will bring together experts from across the world to share information on achievements\, innovations and best practices in dementia research\, care and policy\, while continuing to address and challenge the perceptions around dementia. \nThe conference will follow on from ADI 2022 and be offered in hybrid format\, combining in-person and virtual elements for an educational and interactive experience for delegates. \nThe conference programme will be structured around the 7 action areas of the World Health Organization (WHO)’s Global Action Plan on dementia\, which centre around policy\, awareness\, prevention and diagnosis\, research\, care and treatment of dementia. \nEBC is pleased to be part of this year’s conference and hold the following presentations highlighting the Rethinking Alzheimer’s disease project\, calling for change in Alzheimer ‘s care: \n\nRethinking Alzheimer’s disease: Cross-roads in the earlier detection and diagnosis of Alzheimer’s (poster presentation)\, 24-26 April 2024\nRethinking Alzheimer’s disease: Scaling up health systems’ readiness\, 26 April 2024\, 13:30-15:00
URL:https://www.braincouncil.eu/event/36th-global-conference-of-alzheimers-disease-international/
ATTACH;FMTTYPE=image/jpeg:https://www.braincouncil.eu/wp-content/uploads/2024/01/miedzynarodowa-konferencja-choroby-alzheimera-adi-krakow-2024.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240424
DTEND;VALUE=DATE:20240427
DTSTAMP:20260415T194746
CREATED:20240207T093741Z
LAST-MODIFIED:20240318T133124Z
UID:52305-1713916800-1714175999@www.braincouncil.eu
SUMMARY:Rethinking Alzheimer’s disease: Cross-roads in the earlier detection and diagnosis of Alzheimer's | 36th Global Conference of Alzheimer's Disease International
DESCRIPTION:EBC is pleased to hold a poster presentation “Rethinking Alzheimer’s disease: Cross-roads in the earlier detection and diagnosis of Alzheimer’s” at the upcoming 36th Global Conference of Alzheimer’s Disease International. The Conference will take place from 24-26 April 2024 in Krakow (Poland). The poster will be presented by Charlotte Teunissen\, Professor in Neurochemistry\, Chair of the Neurochemistry lab (Amsterdam UMC) and one of the experts involved in the Rethinking Alzheimer’s disease project. \nAlzheimer’s disease (AD)\, the most common form of dementia\, is a progressive and debilitating neurodegenerative condition which robs people of their memory\, their independence\, their relationships and\, ultimately\, their lives. It affects close to 7 million people in the European Union (EU) alone. \nThe detection and diagnosis of AD relies on a system that remains focused on the late stage of the disease\, despite a better understanding of the disease progression. Clinical practice and healthcare systems’ readiness to detect\, diagnose and treat the disease effectively are still lagging. The use of biomarkers (cerebrospinal fluid tests (CSF) and positron emission tomography scans (PET))\, which are central to a diagnostic assessment for people with AD symptoms\, as well as relevant diagnostic facilities are under-utilised. PET imaging is expensive and of limited availability\, and CSF sampling may be considered invasive. \nThe European Brain Council’s ‘Rethinking Alzheimer’s disease: Detection and diagnosis’ White Paper has looked at the barriers to early diagnosis and how the healthcare systems infrastructure for detection and diagnosis of AD need to be transformed in order for people with AD to benefit from innovative solutions once they become approved for use. The Rethinking Schizophrenia project falls under the Rethinking the management of brain disorders series\, research-driven projects offering policy recommendations to make tangible changes with the aim to improve the lives of people living with brain disorders\, neurological and mental alike\, across Europe. More details about the outcomes of the Rethinking Alzheimer’s disease project can be found in this article. \nSpeakerCharlotte Teunissen  \nProfessor in Neurochemistry\, Chair of the Neurochemistry lab\, Amsterdam UMC.  \nCharlotte Teunissen's drive is to improve care of patients with neurological diseases by developing body fluid biomarkers for diagnosis\, stratification\, prognosis and monitoring treatment responses. Studies of her research group span the entire spectrum of biomarker development\, starting with biomarker identification\, often by –omics methods\, followed by biomarker assay development and analytical validation\, and lastly\, extensive clinical validation and implementation of novel biomarkers in clinical practice.   \nShe has extensive expertise with assay development on state of the art technologies\, such as mass spectrometry and antibody-based arrays for biomarker discovery\, ultrasensitive immunoassays\, and in in implementation of vitro diagnostic technologies for clinical routine lab analysis. She is responsible for the large well-characterised biobank of the Amsterdam Dementia cohort\, containing >6000 paired CSF and serum samples of individuals visiting the memory clinical of the Alzheimer Center Amsterdam  (a.o. controls\, patients with Alzheimer\, Frontotemporal\, Lewy Bodies).To ensure the quality of the biosamples\, the group studies  pre-analytical effects\, which are key to implementation. Charlotte is leading several collaborative international biomarkernetworks\, such as the Society for Neurochemistry and routine CSF analysis and the Alzheimer Association-Global Biomarker Standardization and Blood Based Biomarkers and the Body fluid Biomarkers PIA\, \, and the recently founded Coral proteomics consortium. She is the coordinator of the Marie Curie MIRIADE project\, aiming to train 15 novel researchers into innovative strategies to develop dementia biomarkers (10 academic centers + 10 non-academic centers)\, and the JPND bPRIDE project\, that aims to develop targeted blood based biomarker panels for early differential diagnoses of specific dementias and is a collaborative project between 7 European and 1 Australian centers.  
URL:https://www.braincouncil.eu/event/rethinking-alzheimers-disease-cross-roads-in-the-earlier-detection-and-diagnosis-of-alzheimers/
LOCATION:Krakow\, Poland
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240425
DTEND;VALUE=DATE:20240428
DTSTAMP:20260415T194746
CREATED:20240118T075548Z
LAST-MODIFIED:20240314T150457Z
UID:51688-1714003200-1714262399@www.braincouncil.eu
SUMMARY:13th Neuronus Neuroscience Forum
DESCRIPTION:The Neuronus Neuroscience Forum\, set to take place on 25-27 April 2024\, serves as an international and interdisciplinary conference hosted at the renowned Jagiellonian University in Krakow\, Poland. Its primary aim is to establish a dynamic platform for researchers across different career stages\, facilitating the open exchange of ideas and experiences drawn from diverse corners of the globe. Attendees are provided with a unique opportunity to unveil their research findings\, often marking a significant milestone in their professional journeys. Complementing this\, the event organizes a range of career-enhancing workshops and networking events. The conference program comprehensively covers various facets of neuroscience\, shedding light on the latest research trends and serving as a source of inspiration for all scientists embarking on innovative projects. \nABOUT NEURONUS\nThe main goal of the conference is to provide an opportunity for researchers to share their latest findings\, knowledge and experience\, as well as to make valuable connections with scientists representing different fields of neuroscience. We will encounter reflections on the neurobiological basis of love and on the role of the visual cortex in blind people. We will also learn about the impact of a healthy lifestyle on intelligence or the ageing process. \nThe event programme includes four thematic blocks – Cognitive Neuroscience\, Biological Neuroscience\, Computational Neuroscience and Medical Neuroscience. The first of these presents psychophysiological research\, related to the processing of emotions or perception. The second block is the study of the basic mechanisms of neuroscience\, such as the basis of neurodegenerative diseases. The Computational block focuses on research in neuroinformatics\, such as the development of artificial neural networks. The last block presents issues of neurology and psychiatry and clinical cases of diseases of the nervous system. \nThe schedule includes oral presentations\, poster sessions and plenary lectures by experts in the fields of research on the functioning of the nervous system. This year the invitation was accepted by Quentin Huys (Max Planck Institute\, Germany)\, Sebastian Haesler (Katholieke Universiteit Leuven\, Belgium)\, Jim Haxby (Dartmouth College\, USA)\, Andrew Holmes (University of Newcastle\, USA)\, Gaia Novarino (Institute of Science and Technology\, Austria)\, Katharina Wulff (Umeå Universitet\, Sweden) and Phlippe Schyns (University of Glasgow\, Scotland). \nWHERE AND WHEN?\nThe conference will take place from 25th to 27th of April 2024 at the Auditorium Maximum of the Jagiellonian University. On the day before the conference (24th of April) there will be organized workshops for young scientists on scientific data analysis and career-building\, providing a unique opportunity to gain valuable experience and broaden your skills. \nFind out more!
URL:https://www.braincouncil.eu/event/13th-neuronus-neuroscience-forum/
LOCATION:Krakow\, Poland
ATTACH;FMTTYPE=image/png:https://www.braincouncil.eu/wp-content/uploads/2024/01/poster_2024.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20240426T133000
DTEND;TZID=UTC:20240426T150000
DTSTAMP:20260415T194746
CREATED:20240207T094137Z
LAST-MODIFIED:20240318T134058Z
UID:52307-1714138200-1714143600@www.braincouncil.eu
SUMMARY:Diagnosis\, diagnostic tools and cognitive assessments | 36th Global Conference of Alzheimer's Disease International
DESCRIPTION:EBC is pleased to be part of the session “Diagnosis\, diagnostic tools and cognitive assessments” at the upcoming 36th Global Conference of Alzheimer’s Disease International. The session will take place on 26 April 2024 at 13:30-15:00 in Krakow (Poland). Prof. Giovanni Frisoni will present “Rethinking Alzheimer’s disease: Scaling up health systems’ readiness” as one of the experts involved in the Rethinking Alzheimer’s disease project\, coordinated by EBC. \nAlzheimer’s disease (AD)\, the most common form of dementia\, is a progressive and debilitating neurodegenerative condition which robs people of their memory\, their independence\, their relationships and\, ultimately\, their lives. It affects close to 7 million people in the European Union (EU) alone. \nThe detection and diagnosis of AD relies on a system that remains focused on the late stage of the disease\, despite a better understanding of the disease progression. Clinical practice and healthcare systems’ readiness to detect\, diagnose and treat the disease effectively are still lagging. The use of biomarkers (cerebrospinal fluid tests (CSF) and positron emission tomography scans (PET))\, which are central to a diagnostic assessment for people with AD symptoms\, as well as relevant diagnostic facilities are under-utilised. PET imaging is expensive and of limited availability\, and CSF sampling may be considered invasive. \nThe European Brain Council’s ‘Rethinking Alzheimer’s disease: Detection and diagnosis’ White Paper has looked at the barriers to early diagnosis and how the healthcare systems infrastructure for detection and diagnosis of AD need to be transformed in order for people with AD to benefit from innovative solutions once they become approved for use. The Rethinking Schizophrenia project falls under the Rethinking the management of brain disorders series\, research-driven projects offering policy recommendations to make tangible changes with the aim to improve the lives of people living with brain disorders\, neurological and mental alike\, across Europe. More details about the outcomes of the Rethinking Alzheimer’s disease project can be found in this article. \nSpeakerGiovanni B Frisoni\, neurologist \nClinical neurologist\, Full Professor of Clinical Neuroscience at the University of Geneva\, Switzerland\, and Director of the Memory Clinic of the Geneva University Hospital. Former Scientific Director at the National Alzheimer’s Centre in Brescia\, Italy. Author of over 700 scientific papers listed in PubMed\, imaging editor for Neurobiology of Aging\, and founding editorial board member of The Lancet Neurology. Has led national and international projects funded by the European Commission\, IMI\, the Alzheimer’s Association\, Italian and Swiss Ministry of Health\, and industry. Chairman of Alzheimer’s Imaging Consortium at International Conference on Alzheimer’s Disease in 2010 and 2011. Honorary member of the Austrian Neurological Society and of the French Society of Neurology\, he has received the Investigator Award Winner of European Academy of Neurology in 2016.
URL:https://www.braincouncil.eu/event/diagnosis-diagnostic-tools-cognitive-assessments/
LOCATION:Krakow\, Poland
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240502
DTEND;VALUE=DATE:20240504
DTSTAMP:20260415T194746
CREATED:20240117T143210Z
LAST-MODIFIED:20240429T075052Z
UID:51679-1714608000-1714780799@www.braincouncil.eu
SUMMARY:Tech Tour Mental & Brain Health
DESCRIPTION:The very first edition of the Tech Tour Mental & Brain Health will take place next 2-3 May 2024 at the Nova Business School in the Carcavelos Campus in Carcavelos\, Portugal. \nThe Investment Programme & Event will aim to bring together 30-40 of the most promising Mental Health & Brain tech companies\, as selected by 40 of the most active investors and corporate partners in the sector. \nThe Mental & Brain Health event agenda includes 2 days of: \n\npitches\nmeetings\nkeynotes\npanel discussions\nnetworking opportunities.\n\nEBC Deputy Executive Director Stephanie Kramer will participate in a panel discussion “Is – or how can we make – mental health and brain health a government policy priority?” on 2nd of May at 19:00\, in the Auditorium. \nThe members of the EBC network can benefit from 20% discount code. If you are part of our network\, please get in contact with us at advocacy@braincouncil.eu. \nFind out more!Discover the programme!
URL:https://www.braincouncil.eu/event/tech-tour-mental-brain-health/
ATTACH;FMTTYPE=image/jpeg:https://www.braincouncil.eu/wp-content/uploads/2024/01/2023-LargeBanner-MentalBrainHealth.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240503
DTEND;VALUE=DATE:20240504
DTSTAMP:20260415T194746
CREATED:20240404T082746Z
LAST-MODIFIED:20240404T082746Z
UID:53798-1714694400-1714780799@www.braincouncil.eu
SUMMARY:Be Open About Animal Research Day
DESCRIPTION:The European Animal Research Association (EARA)’s fourth edition of ‘Be Open About Animal Research Day’ (#BOARD24) will take place on Friday 3 May 2024. \n#BOARD24 is a global\, 24-hour social media campaign that celebrates openness by biomedical institutions in communicating animal research. Participants from around the world share their stories and experiences of being open about animal research with the public\, including case studies\, videos and events. \nJOIN THE CAMPAIGN
URL:https://www.braincouncil.eu/event/be-open-about-animal-research-day/
ATTACH;FMTTYPE=image/png:https://www.braincouncil.eu/wp-content/uploads/2024/04/BOARD24-initial.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240508
DTEND;VALUE=DATE:20240510
DTSTAMP:20260415T194746
CREATED:20230719T133355Z
LAST-MODIFIED:20240529T082441Z
UID:48264-1715126400-1715299199@www.braincouncil.eu
SUMMARY:10th Academy of National Brain Councils
DESCRIPTION:Look Back at the 10th National Brain Councils AcademyThe 10th National Brain Councils Academy (NBCs) was held from 8 to 9 May 2024 in Pula\, more precisely on the island of Brijuni in Croatia. This year\, the meeting was integrated into the 3rd International Conference on Neurological Disorders and Neurorestoration\, which took place from 9 to 12 May 2024.\n\nThis annual event brought together several representatives from European NBCs\, both online and in person. No less than 11 countries were represented\, including Belgium\, Croatia\, Finland\, Germany\, Greece\, Italy\, Norway\, Serbia\, Spain\, Sweden and Switzerland.\nFurthermore\, we were pleased to welcome Karim Berkouk (Policy Officer\, Directorate-General for Research and Innovation\, European Commission) and to receive a video message from Dr Neerja Chowdhary (Technical Officer\, World Health Organization (WHO). The themes of their sessions were respectively “Update of the Intersectoral Global Action Plan on Epilepsy and Other Neurological Disorders” and “Analysis of the Impact of AI in Science Policies for Neuroscience and Health”. During the meeting\, the NBCs shared their insights on the good practices and the national strategies for advancing brain health in Europe. They provided updates on their respective national brain health plans.\nAdditionally\, the European Brain Council (EBC) presented an overview of its EU Elections Manifesto 2024\, highlighting the importance of placing brain health and research at the top of the policy agenda\, both at the EU and national levels.\n\n“We call on the European Parliament and European Commission 2024-2029 to support policy making towards equitable and quality brain health to combat brain challenges\, promote societal cohesion\, boost economic productivity and guide the EU to the role of global leader in brain research.”– Frédéric Destrebecq\, Executive Director\, European Brain Council\n \nThe focus of the second part of the programme shifted towards data\, with a panel discussion dedicated to the establishment of the European Brain Health Data Hub\, an association proposing to share patient data among European health institutions. The aim of this new initiative is to enhance research on mental health\, particularly by addressing gaps in data availability. This initiative from the Belgian Brain Council\, led by Roland Pochet (Secretary General\, Belgian Brain Council) and Gregory Lewkowick (Professor\, University of Brussels) was endorsed by the Belgian Deputy Prime Minister and Minister of Economy and Labour\, Pierre-Yves Dermagne.\n\n\nFinally\, the meeting of the 10th NBCs Academy was all the more important this year\, as it took place ahead of a major milestone\, the European elections\, set to take place on 6-9 June 2024. This will be a crucial opportunity for the brain community to shape the future of European brain health\, research\, and innovation.\n\nLearn more about National Brain CouncilsLearn moreLearn more
URL:https://www.braincouncil.eu/event/10th-academy-of-national-brain-councils/
LOCATION:Pula\, Croatia\, Pula\, Croatia (Local Name: Hrvatska)
ATTACH;FMTTYPE=image/png:https://www.braincouncil.eu/wp-content/uploads/2023/07/Event-attendance-4.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240509
DTEND;VALUE=DATE:20240513
DTSTAMP:20260415T194746
CREATED:20230728T104825Z
LAST-MODIFIED:20230802T074014Z
UID:48418-1715212800-1715558399@www.braincouncil.eu
SUMMARY:3rd International Conference on Neurological Disorders and Neurorestoration
DESCRIPTION:The International Conference on Neurological Disorders and Neurorestoration will be held from 9th – 12th May 2023 in Brijuni National Park\, Croatia. \nThis unique international meeting will cover a wide range of areas connected to neurology\, neuroscience and neurorestoration\, such as neuroinflammation\, neurodegeneration\, ischemic diseases\, paroxysmal and extrapyramidal diseases. The School of Medicine of the University of Zagreb\, supported by all clinics for neurology of the Zagreb Clinical and Hospital Centers\, is the main organizer of the conference. \nThe conference will be organized in conjunction with the 10th Academy Meeting of National Brain Councils that will be held from 8th – 9th May. \nMore information about the event will be available soon. \nPDF Presentation
URL:https://www.braincouncil.eu/event/3rd-international-conference-on-neurological-disorders-and-neurorestoration/
LOCATION:Brijuni National Park\, Croatia\, Brijuni\, Croatia (Local Name: Hrvatska)
ATTACH;FMTTYPE=image/png:https://www.braincouncil.eu/wp-content/uploads/2023/07/Design-sans-titre-20.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240511
DTEND;VALUE=DATE:20240517
DTSTAMP:20260415T194746
CREATED:20240318T090926Z
LAST-MODIFIED:20240318T090926Z
UID:53605-1715385600-1715903999@www.braincouncil.eu
SUMMARY:16th World Congress of the International Neuromodulation Society
DESCRIPTION:Neuromodulation: Harnessing the Power of the Nervous System\n\n\n\n\n\n\n\nThe theme will emphasize the field’s transformative force on disease treatment and proven therapies delivered with refined and personalized techniques. \nThe 16th INS World Congress (INS 2024)\, will bring together over 1\,500 scientists\, researchers\, engineers\, device developers\, and healthcare providers to advance the neuromodulation field. Witness the best scientific and teaching programs and ground-breaking research. The theme will emphasize the field’s transformative force on disease treatment and proven therapies delivered with refined and personalized techniques. \n\n\n\n\n\n\nMore information and registration
URL:https://www.braincouncil.eu/event/16th-world-congress-of-the-international-neuromodulation-society/
LOCATION:Vancouver\, Canada
ATTACH;FMTTYPE=image/png:https://www.braincouncil.eu/wp-content/uploads/2024/03/INS-2024.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240514
DTEND;VALUE=DATE:20240516
DTSTAMP:20260415T194746
CREATED:20240314T082545Z
LAST-MODIFIED:20240314T082823Z
UID:53507-1715644800-1715817599@www.braincouncil.eu
SUMMARY:Belgian Brain Council Symposium | Altruistic Data Association
DESCRIPTION:On May 14 and 15\, 2024\, the Belgian Brain Council is organizing a symposium that will officially inaugurate the creation of an Altruistic Data Association. This creation is the result of the application of the European Data Governance Act (DGA)\, which encourages the voluntary sharing of data for altruistic purposes such as scientific research or the improvement of public services. \nThis symposium will present the fruit of our interactions with the political world\, scientific experts and the trust placed in the BBC by its 25 patient associations and 22 scientific societies. This symposium is aimed at a wide audience interested in data sharing in the healthcare sector. There are 150 places available. \nThe political debates and the session where patient associations have their say will be translated into French and Dutch in real time. The scientific session will be in English.  Online participants will be able to ask questions via the Slido platform. Reservations will be open from March 15\, 2024. The program includes the active participation of politicians\, scientists\, patient associations\, members of the European Commission\, the Belgian Health Data Agency and the Brain Councils of 5 other member states who have decided to join forces. It will be a hybrid event\, meaning it can be taken online or in person. \nRegistrationProgramme
URL:https://www.braincouncil.eu/event/belgian-brain-council-symposium-altruistic-data-association/
LOCATION:University Foundation\, Rue d'Egmont 11\, Brussels\, 1000\, Belgium
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240515
DTEND;VALUE=DATE:20240517
DTSTAMP:20260415T194746
CREATED:20240112T103916Z
LAST-MODIFIED:20240112T103916Z
UID:51524-1715731200-1715903999@www.braincouncil.eu
SUMMARY:12th European Conference on Rare Diseases & Orphan Products
DESCRIPTION:The 12th European Conference on Rare Diseases & Orphan Products (ECRD) is the largest\, patient-led\, rare disease policy-shaping event held in Europe. \nBy bringing together people with rare diseases and patient advocates\, policy makers\, healthcare industry representatives\, clinicians\, regulators and Member State representatives\, EURORDIS harnesses the power of this extensive network to shape goal-driven rare disease policies of the future. \nWith over 1000 participants\, the Conference is an unrivalled opportunity to network and exchange invaluable insights within the rare disease community. Through collaborative efforts\, these discussions culminate in clear policy recommendations that can influence both EU and national policies. \nGet ready for the next ECRD\, a fully hybrid conference taking place on 15 & 16 May 2024 online and at The Square in Brussels. \nRegistration is now open with a limited number of 300 places available to join us in person and early-bird fees available until 2 February!  \nFind out more!For privacy reasons YouTube needs your permission to be loaded. For more details\, please see our Privacy Policy.I Accept
URL:https://www.braincouncil.eu/event/12th-european-conference-on-rare-diseases-orphan-products/
ATTACH;FMTTYPE=image/png:https://www.braincouncil.eu/wp-content/uploads/2024/01/ECRD-banner_1245x328.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240515
DTEND;VALUE=DATE:20240518
DTSTAMP:20260415T194746
CREATED:20240122T144328Z
LAST-MODIFIED:20240122T144505Z
UID:51808-1715731200-1715990399@www.braincouncil.eu
SUMMARY:10th European Stroke Organisation Conference – ESOC 2024
DESCRIPTION:ESOC is Europe’s leading forum for advances in research and clinical care of patients with cerebrovascular diseases. ESOC 2024\, hosted exclusively onsite in Basel\, Switzerland\, presents an exceptional conference experience\, providing an outstanding scientific programme with major clinical trials\, workshops\, and debates aimed at connecting colleagues across various disciplines\, institutes\, and countries. \nMore informationRegistration
URL:https://www.braincouncil.eu/event/10th-european-stroke-organisation-conference-esoc-2024/
LOCATION:Congress Center and Messe Basel\, Messeplatz\, Basel\, 4058\, Switzerland
ATTACH;FMTTYPE=image/jpeg:https://www.braincouncil.eu/wp-content/uploads/2024/01/02-ESOC-Linkedin-1774x4442-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20240516T130000
DTEND;TZID=UTC:20240516T160000
DTSTAMP:20260415T194746
CREATED:20240429T124520Z
LAST-MODIFIED:20240429T124520Z
UID:54012-1715864400-1715875200@www.braincouncil.eu
SUMMARY:HealthTech For Patients
DESCRIPTION:HealthTech For Patients (HTFP) serves as a platform for patients to express their needs and discover innovations in healthcare by reuniting health innovation stakeholders. The goal is to put the patient at the center of innovation. This event aims to bridge the gap between healthcare professionals and patients\, establishing an open exchange platform that enables professionals to better understand the perspectives\, needs\, and experiences of patients. \nThe theme of this year’s edition is “Inside Mental Health: Causes and Environment” with two insightful roundtable discussions: \n\n“The Impact of Illness on Mental Health: From Screening to Post-Treatment”\n“Mental Health in a Challenging World: The Impact of Environment”\n\nEBC Executive Director Frédéric Destrebecq is pleased to be a speaker in the Keynote on Clinical Aspect of the first roundtable discussion. \nPROGRAMMEREGISTRATIONMORE INFORMATION
URL:https://www.braincouncil.eu/event/healthtech-for-patients/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://www.braincouncil.eu/wp-content/uploads/2024/04/banniere-HTFP-2024-2-002.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20240526T093000
DTEND;TZID=UTC:20240526T143000
DTSTAMP:20260415T194746
CREATED:20240314T081648Z
LAST-MODIFIED:20240426T140432Z
UID:53505-1716715800-1716733800@www.braincouncil.eu
SUMMARY:Brussels 20KM Run – #Move4YrBrain
DESCRIPTION:The European Brain Foundation joins forces with the European Brain Council to shed light on the benefits of physical exercise for the brain\, reactivating the #Move4YrBrain campaign. Physical activity and healthy lifestyles have a clear and demonstrated impact on brain health. Whether you’re running\, walking\, or jogging\, let’s lace up our shoes\, hit the pavement\, and boost our brain health together! \nShare your runs\, walks\, or jogs with us using #Move4YrBrain or by joining our Strava group. We encourage each and every one of you to start – or keep – exercising and share your pictures on social media with the hashtag #Move4YrBrain\, or our website. T-shirts can be made available upon request.  \nAs part of the #Move4YrBrain Campaign\, members of the EBC team will also take part in the 20KM of Brussels on May 26\, a sport event dedicated to handisport\, runners and walkers. \nRegistrations to the 20km of Brussels are now officially sold out. The last race numbers will go on sale on 2 May at 9am on the organizers’ website. \nJoin the Team20KM of BrusselsMove4YrBrain
URL:https://www.braincouncil.eu/event/brussels-20km-run/
LOCATION:Parc du Cinquantenaire\, Parc du Cinquantenaire\, Brussels\, 1000\, Belgium
ATTACH;FMTTYPE=image/png:https://www.braincouncil.eu/wp-content/uploads/2024/03/Madrid-7.png
ORGANIZER;CN="European Brain Council":MAILTO:advocacy@braincouncil.eu
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240606
DTEND;VALUE=DATE:20240610
DTSTAMP:20260415T194746
CREATED:20240313T092102Z
LAST-MODIFIED:20240409T134041Z
UID:53412-1717632000-1717977599@www.braincouncil.eu
SUMMARY:2024 European Elections
DESCRIPTION:While brain disorders cost the European Union an estimated €800 billion every year (a number widely considered to be outdated and much higher as of 2024)\, we have yet to have a full understanding of their underlying mechanisms and of the brain itself\, mainly due to how incredibly complex this organ is. Consequently\, a large number of brain conditions remain without a disease-modifying therapy or cure. \nInstead of divesting in a cost\, to meet this growing burden\, policymakers and society at large should view the prioritization and support of brain research as an investment into prevention\, wellness and optimization\, creating a better future for each and every one of their constituents. Concerted action to improve access to prevention\, effective and timely diagnosis\, treatment\, rehabilitative and supportive care is sorely needed to achieve potential savings and improve EU citizens’ quality of life. Brain conditions\, neurological and mental alike\, must be made an European priority\, through both policymaking and economic prioritisation. \nThe upcoming 2024 European Election is thus a crucial milestone for the entire brain community. By participating in the electoral process\, we can shape the future of brain health\, research\, and innovation in the EU\, ultimately leading to better outcomes for individuals and societies alike. On this page\, you will find relevant materials to help you engage in this process\, and making sure the voice of our community is heard. \n2024 Elections ManifestoGlobal Call to actionPledge for scienceBetween 6–9 June 2024\, millions of Europeans will participate in shaping the future of European democracy on the occasion of the European elections. \nIt is a unique moment when we can all collectively decide on the future of the European Union. Voting is always important\, be it at local\, national or European level. It is an excellent opportunity to have your say on topics you care about. \nIt can be easy to forget how many people are impacted by the outcome of the European elections. The European Parliament adopts laws that affect everyone: large countries and small communities\, powerful companies and young start-ups\, the global and the local. \nEU laws tackle most people’s priorities: the environment\, security\, migration\, social policies\, consumer rights\, economy\, rule of law and many more. Today\, every important national topic also has a European angle. \nYour vote will decide which Members of the European Parliament will represent you in preparing new laws and will influence the election of the European Commission. These decisions will shape your daily life and that of many others. \nUseful ResourcesFor privacy reasons YouTube needs your permission to be loaded. For more details\, please see our Privacy Policy.I AcceptGeneral InformationWhat europe does for meRemind me to voteCurrent Projects funded by the European Union
URL:https://www.braincouncil.eu/event/2024-european-elections/
ATTACH;FMTTYPE=image/jpeg:https://www.braincouncil.eu/wp-content/uploads/2024/03/EE24_VOTE_EN.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20240624T100000
DTEND;TZID=UTC:20240624T120000
DTSTAMP:20260415T194746
CREATED:20240617T112719Z
LAST-MODIFIED:20240617T113332Z
UID:54610-1719223200-1719230400@www.braincouncil.eu
SUMMARY:2024 Thematic Networks: Pitch webinar - Meet the leaders\, learn about their proposals\, EUHPP Live Webinar
DESCRIPTION:The European Commission is organising the 2024 Thematic Networks Pitch webinar – Meet the leaders\, learn about their proposals on June 24\, 2024. The following four Thematic Networks will be presented: \n\n“Advancing Precision Medicine for Europe’s Cancer Patients with AIpowered Imaging”\n“Profiling Cancer Genomes using AI and Natural Language Processing – Methodologies for Hotspot Identification”\n“Beyond Boundaries: A Global Continuum for healthy generations”\n“Towards an EU Coordination Plan for the Brain”\n\nThis will be the opportunity for EBC to explain the goals and scope of its new Thematic Network\, Towards an EU Coordination Plan for the Brain. More details can be found on the European Commission website\, or by clicking on the button below. \nMore information & Agenda
URL:https://www.braincouncil.eu/event/2024-thematic-networks-pitch-webinar-meet-the-leaders-learn-about-their-proposals-euhpp-live-webinar/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://www.braincouncil.eu/wp-content/uploads/2024/06/Logo-FV2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240625
DTEND;VALUE=DATE:20240630
DTSTAMP:20260415T194746
CREATED:20240103T133927Z
LAST-MODIFIED:20240605T082637Z
UID:51270-1719273600-1719705599@www.braincouncil.eu
SUMMARY:FENS Forum 2024
DESCRIPTION:The Federation of European Neuroscience Societies (FENS)\, the Austrian Neuroscience Association (ANA) and the Hungarian Neuroscience Society are delighted to welcome you to the FENS Forum 2024\, taking place in Vienna\, Austria\, from 25-29 June 2024. \nThe FENS Forum is Europe’s largest neuroscience congress\, covering all areas of neuroscience from basic to translational research. FENS Forum 2024 will feature an exciting programme of plenary and special lectures\, scientific symposia\, technical workshops\, special interest events\, career development and networking opportunities and so much more! \nEBC looks forward to being part of the exhibition area and holding the following sessions at the Forum: \n\nPrioritizing Brain Health in Youth: Bringing Neuroscience to Society and Informing Policy\, Mini Conference\, 25 June 2024\, 10:00-12:00\nDiscover the European Brain Council at the FENS Booth\, 26 June 2024\, 13:30-14:15\nEnhancing Global Partnerships in Brain Research\, Networking Reception\, 27 June\, 18:45-20:15\n\nFind out more
URL:https://www.braincouncil.eu/event/fens-forum-2024/
LOCATION:Messe Wien Exhibition & Congress\, Messepl. 1\, Wien\, 1020\, Austria
ATTACH;FMTTYPE=image/png:https://www.braincouncil.eu/wp-content/uploads/2024/01/FENS-Forum-2024-main-image-LinkedIn.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20240625T100000
DTEND;TZID=UTC:20240625T120000
DTSTAMP:20260415T194746
CREATED:20240112T073030Z
LAST-MODIFIED:20240610T111734Z
UID:51516-1719309600-1719316800@www.braincouncil.eu
SUMMARY:Prioritizing Brain Health in Youth: Bringing Neuroscience to Society and Informing Policy | 2024 FENS Forum Mini Conference
DESCRIPTION:EBC is pleased to hold a Mini Conference ‘Prioritizing Brain Health in Youth: Bringing Neuroscience to Society and Informing Policy‘ at the upcoming FENS Forum. The event will take place on 25 June 2024 at 10:00-12:00. \nLocation: HALL B\, Messe Wien Exhibition & Congress Center\, Vienna Austria \nAccording to OECD half of the population will have to contend with mental health problems at some point in their life. Two-thirds of mental health disorders manifest before age 25. Good brain health plays a significant role in an individual’s well-being and profoundly impacts the collective economy and society. Today there is an urgent action needed on failing youth mental health. Neuroscience and brain development are key to address the situation. Understanding neural circuits is critical for gaining insights into the etiology of mental disorders. Brain development does not stop at birth and some aspects continue throughout infancy\, childhood\, and adolescence\, allowing the full development of cognitive functions. Different determinants related to physical health\, healthy environments\, safety and security\, life-long learning\, and social connection as well as access to quality services influence the way our brains develop\, adapt\, and respond to stress and adversity. Ongoing progress in neurobiology and cognitive neuroscience allow the design of better prevention and intervention strategies to help avoid brain deficits and/or limit their impact and maintain brain health.   \nAlthough effective early detection and interventions exist\, there are numerous unmet needs along the mental health care pathways. Navigating the mental health services system is often complex for patients and families due to fragmented services and discontinuity of care. Policies and programs to prevent and mitigate the negative impacts on schooling\, employment\, families\, and risky behaviors are also paramount. The European Commission’s communication on a comprehensive approach to mental health released in June 2023 is a step forward but requires more commitment to boost children and young adult’s mental health. The European Brain Council (EBC) and the Federation of European Neuroscience Societies (FENS) will convene a Mini Conference on 25 June at the upcoming FENS Forum 2024 in Vienna to address these challenges. The event will explore what the opportunities are of incorporating a transdiagnostic and biopsychosocial-informed perspective. The meeting will bring together neuroscientists\, clinicians\, researchers\, policymakers\, patients & caregivers to raise awareness on brain health\, bridging the gap between research\, policy\, and society.  \nFinal Programme and Speakers FENS\nDISCOVER THE PROGRAMME AND THE SPEAKERSAll FENS Forum participants can join the Mini Conference without extra registration. Registration for external participants has closed. Those that registered on time will have access to the FENS Forum 2024 for the whole day of 25 June 2024.
URL:https://www.braincouncil.eu/event/2024-fens-forum-mini-conference/
ATTACH;FMTTYPE=image/jpeg:https://www.braincouncil.eu/wp-content/uploads/2024/01/FENS-Forum-2024-Mini-Conference-2-scaled.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240627
DTEND;VALUE=DATE:20240629
DTSTAMP:20260415T194746
CREATED:20240329T132819Z
LAST-MODIFIED:20240329T132819Z
UID:53773-1719446400-1719619199@www.braincouncil.eu
SUMMARY:10th European Alcohol Policy Conference
DESCRIPTION:About the event \nThe 10th European Alcohol Policy Conference (EAPC) is scheduled to take place in Ljubljana\, Slovenia\, on the 27th and 28th of June 2024. This conference is organized by Eurocare in collaboration with the Youth Health Organisation and will be hosted at the InterContinental Hotel (located at Slovenska cesta 59\, 1000 Ljubljana\, Slovenia). Additionally\, preceding the conference\, the Annual General Meeting of Eurocare members will convene in Ljubljana on the 26th of June. \nPolicymakers\, advocates\, researchers\, patients\, youth\, and health practitioners will gather in Ljubljana to address the challenges of reducing non-communicable diseases (NCDs) with a special focus on alcohol policies. \nEarly bird registration fees will commence at 250 EUR per participant. \nAim \nThe 10th European Alcohol Policy Conference serves as a vital platform for policymakers\, advocates\, researchers\, patients\, youth\, and health practitioners to collectively address the challenges of reducing non-communicable diseases (NCDs) by effectively managing their main risk factors\, with a special focus on alcohol policies. Through discussions on topics like the Commercial Determinants of Health\, interventions related to packaging and labelling regulations\, awareness campaigns\, and effective measures against corporate lobbying at EU and national level\, the conference aims to foster mutual learning and respect\, ultimately leading to comprehensive strategies to reduce NCDs. \nBackground \nBuilding upon the successes of its predecessors\, the 10th European Alcohol Policy Conference comes at a crucial time\, coinciding with significant developments such as the new EU mandate\, the continuation of the European Framework of Action on Alcohol 2022-2025\, the launch of the Member States Joint Action Prevent Non-communicable Diseases\, as well as international discussions on alcohol labelling within the Codex Alimentarius Commission. With mounting evidence showcasing the impact of commercial entities on health outcomes\, it’s imperative to address the complexities of alcohol policy within the broader context of NCD prevention. \nREAD MORE ABOUT THE EVENT
URL:https://www.braincouncil.eu/event/10th-european-alcohol-policy-conference/
LOCATION:Ljubljana\, Slovenia
ATTACH;FMTTYPE=image/png:https://www.braincouncil.eu/wp-content/uploads/2024/03/10TH-CONFERENCE.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20240627T184500
DTEND;TZID=UTC:20240627T201500
DTSTAMP:20260415T194746
CREATED:20240305T072651Z
LAST-MODIFIED:20240717T063927Z
UID:53232-1719513900-1719519300@www.braincouncil.eu
SUMMARY:Enhancing Global Partnerships in Brain Research | 2024 FENS Forum Networking Reception
DESCRIPTION:Location: HALL E\, Messe Wien Exhibition & Congress Center\, Vienna Austria \nAcross the globe\, society is facing brain challenges like never before. Brain disorders – neurological and mental alike – are widespread\, highly disabling and often difficult to treat. In fact\, it is estimated that up to one billion people worldwide live with a neurological condition and 970 million people around the world were living with a mental health disorder as of 2019\, with anxiety and depressive disorders the most common. These conditions represent a high individual\, social and economic burden and contribute to the global disease burden and disability. \nImproving the health and well-being of citizens has become the top priority for many governments and brain health should not be left behind. Enhancing global brain research collaboration can spur innovation and quicken effective outcomes to the benefit of people living with brain conditions everywhere. \nOver the last few years\, EBC has served as a convener for experts in the brain community to share best practices\, exchange ongoing work and align priorities to forge a joint path forward to understand and address the brain rather than in silos across continents. \nTo move past discussion and work towards explicit and tangible next steps in solidifying global efforts in brain research\, EBC is actively involved in engaging the community in relevant areas for action\, including advocating for the recognition of brain health as an urgent priority in planning for Global Action Plans and national brain health plans/strategies and the development of policy recommendations to guide national\, regional and global policymakers towards better addressing brain health in the future. Part of this is through direct engagement within the Coordination and Support Action BrainHealth\, launched at the end of 2023 to prepare the future European Brain Health Partnership. \nThis event\, aimed to bring the global brain research community together on the occasion of the FENS Forum to network and build synergies in an informal setting\, will also feature a short panel discussion with key stakeholders working across continents to unite the brain research community globally. \nEBC Networking Event at the FENS Forum 2024 - Final\nDownload the ProgrammeSpeakersGeorge BarettoIBRO Latin America Regional Committee (LARC) Dr George Barreto earned his PhD in Neuroscience (2009) from the Universidad Complutense Madrid (Spain) studying the effects of neurosteroids on reactive glia with traumatic brain injury. His Post-doctoral training in Neuroscience at Stanford University School of Medicine (2009-2011) focused on addressing the role of astrocytes activation following stroke and enhance astrocytic functions targeting neuronal protection. Nowadays Dr George Barreto is a Senior Lecturer (Associate Professor) in Cell Biology/Immunology in the Department of Biological Sciences\, University of Limerick (UL\, Ireland) and a member of the Health Research Institute from the same University. He is also the ERASMUS contact point within the Dept and member of the EDF Steering Committee and Events and Media subgroup\, the Chair of Action Plan subgroup in the Equality\, Diversity and Inclusion Forum Committee\, and the Athena Swan Steering Committee at UL. Dr Barreto is also a member of the IBRO Latin America Regional Committee (LARC) and served as President of the Colombian Neuroscience Society (COLNE) in 2014-2018. He has served in numerous grants panels and editorial boards and is nowadays the Section Editor in Neuroendocrinology for Pharmacological Research.\nHis main research interests are to better understand how natural and synthetic androgens and estrogens affect brain functions\, particularly on how these hormones control the mitochondrial functions in the healthy and diseased brain during lifespan in a sex-dependent manner (UN SDGs 3 and 5). \nUlrike BußhoffCoordinator\, CSA BrainHealth Dr. Ulrike Busshoff is Head of the International Health Research Department at the DLR Project Management Agency (DLR-PT)\, Germany. She oversees national\, European and international research funding programmes in the area of brain health and global health. Besides conceptualizing and executing research funding programs on behalf of the German Federal Ministry of Education and Research she is also responsible for overarching topics like patient and public involvement\, quality assurance in biomedical research\, and ethical issues. Dr. Busshoff is the coordinator of the ERA-Net NEURON (Network of European Funding for Neuroscience Research) that comprises ministries and funding agencies from 27 countries in and beyond Europe. Members in this network collaborate along a common research agenda\, and with support by the European Commission to jointly fund research\, networking and training activities in the area of neurological and mental disorders. Since 2023\, Dr. Busshoff is also the coordinator of the CSA BrainHealth. This EU funded network conceptualizes and prepares a European Partnership for Brain Health. This large-scale endeavour will support brain health research and innovation with the ultimate goal to preserve and promote brain health. She serves also as member of the Advisory Board EU-Africa PerMed\, an EU funded coordination and support action fostering joint projects in personalised medicine research between Europe and Africa. Dr. Busshoff holds a PhD in neurobiology from the University of Heidelberg\, including research stays in the Netherlands as well as South Korea. \nStephanie KramerDeputy Executive Director EBC Stephanie Kramer joined EBC in March 2016 within the projects team\, eventually making the move to heading the Communications\, Advocacy & Policy team until 2023. Aside from the day to day\, Stephanie’s role as Deputy Director continues to oversee the Communications & Advocacy work\, with a more strategic role focused on EBC’s global partnerships portfolio\, external relations and larger-scale advocacy events. \nStephanie holds an LLM in International Law from the University of Edinburgh\, and a BA in International Relations & Diplomacy from Schiller International University Heidelberg & Madrid. An expat since childhood\, before starting her career in the Brussels bubble she had previous communications\, external relations and project management experience at the United Nations headquarters in Vienna and private sector companies in the Netherlands and Chile. \nMahmoud Bukar MainaSociety of Neuroscientists of Africa (SONA) Dr Mahmoud Bukar Maina is an Independent Research Fellow Research Fellow at Sussex Neuroscience (UK) and visiting scientist at Yobe State University (Nigeria). He obtained a BSc in Human Anatomy from the University of Maiduguri\, Nigeria and a PhD in Neuroscience from the University of Sussex\, UK. His research majorly focuses on understanding the basic mechanism of disease in Alzheimer’s disease\, with a special focus on the role of Tau\, amyloid beta and APOE. Concurrently\, his work partly focuses on generating human-induced pluripotent stem cell-derived brain models from indigenous African populations to understand Dementia mechanisms.\nDr Maina is also passionate about open science and inspiring/training the next generation of African scientists. He recently established the Biomedical Science Research and Training Centre in Nigeria (BioRTC – www.BioRTC.com) to facilitate neuroscience research in Africa. In addition\, he is the Outreach Coordinator for TReND in Africa\, the founder of Science Communication Hub Nigeria and the African Science Literacy Network to increase access to science role models and public understanding of science in Africa. His work and science engagement activities have been supported by the Wellcome Trust\, Chan Zuckerberg Initiative\, Alzheimer’s Research UK and the University of Sussex. He has received many awards\, including the Royal Society of Biology Science Communication Award in 2017\, the young African of the year nomination for the Future Awards Africa\, the New England Biolabs Passion for Science Humanitarian Duty Award in 2019 and the 2022 ALBA-FKNE Diversity Prize for promotion of basic neuroscience in Africa. In 2020\, he was endorsed by the Royal Society as a Global Talent. \nJohn J. NgaiDirector NIH BRAIN Initiative Dr John J. Ngai\, Ph.D.\, is the Director of the NIH’s Brain Research Through Advancing Innovative Neurotechnologies®(BRAIN) Initiative. Dr. Ngai earned his bachelor’s degree in chemistry and biology from Pomona College\, Claremont\, California\, and Ph.D. in biology from the California Institute of Technology (Caltech) in Pasadena. He was a postdoctoral researcher at Caltech and at the Columbia University College of Physicians and Surgeons before starting his faculty position at the University of California at Berkeley. During more than 25 years as a Berkeley faculty member\, Dr. Ngai has trained 20 undergraduate students\, 24 graduate students and 15 postdoctoral fellows in addition to teaching well over 1\,000 students in the classroom. His work has led to the publication of more than 70 scientific articles in some of the field’s most prestigious journals and 10 U.S. and international patents. Dr. Ngai has received many awards including from the Sloan Foundation\, Pew Charitable Trusts\, and McKnight Endowment Fund for Neuroscience. As a faculty member\, Dr. Ngai has served as the director of Berkeley’s Neuroscience Graduate Program and Helen Wills Neuroscience Institute. He has also provided extensive service on NIH study sections\, councils and steering groups\, including as previous co-chair of the NIH BRAIN Initiative Cell Census Consortium Steering Group. Dr. Ngai oversees the long-term strategy and day-to-day operations of the NIH BRAIN Initiative as it strives to revolutionize our understanding of the brain in both health and disease. \nSuzanne DicksonPresident EBC \n\n\n\n\n\n\n\nProfessor Suzanne L Dickson is a neurobiologist and Professor of Neuroendocrinology at the University of Gothenburg. She graduated with a Ph.D. in Neuroendocrinology from the University of Cambridge in 1993\, where she later became Senior Lecturer in Physiology. She is a leading figure in neuroendocrinology and works within many European Union and international organisations and societies to promote research\, facilitate grant funding and training of Early Career Scientists. Her research into the neurobiology of appetite aims to unravel neurobiological pathways that respond to orexigenic signals\, such as the hormone\, ghrelin\, and that drive feeding behaviours\, not only food intake but also food choice\, food anticipation\, food reward and food motivation. This work involves mostly preclinical studies and includes behavioural tasks\, viral vector mapping\, chemogenetics and RNAscope. She is Secretary and Executive Board member of the European College for Neuropsychopharmacology\, and also chairs ECNP’s Workshop for Early Career Scientists in Europe. She also is founder and co-chair of ECNP’s nutrition network and EBRA’s BRAINFOOD cluster.
URL:https://www.braincouncil.eu/event/enhancing-global-partnerships-in-brain-research-2024-fens-forum-networking-reception/
LOCATION:Messe Wien Exhibition & Congress\, Messepl. 1\, Wien\, 1020\, Austria
ATTACH;FMTTYPE=image/png:https://www.braincouncil.eu/wp-content/uploads/2024/03/FENS-2024-Enhancing-Global-Partnerships-in-Brain-Research-Final.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240629
DTEND;VALUE=DATE:20240703
DTSTAMP:20260415T194746
CREATED:20231128T143124Z
LAST-MODIFIED:20240531T095538Z
UID:50561-1719619200-1719964799@www.braincouncil.eu
SUMMARY:10th Congress of the European Academy of Neurology
DESCRIPTION:The 10th annual congress of the European Academy of Neurology will take place in Helsinki (Finland) and online on 29 June – 2 July\, 2024. \nThe Overarching Theme for EAN 2024 is ‘Neuromodulation: advances and opportunities in neurological diseases’\, with numerous sessions planned around this important and engaging topic. \nAs usual\, the congress programme will be bursting with Symposia\, Workshops\, Teaching Sessions\, and much more\, including some exciting Named Lectures from eminent invited speakers. \nEBC looks forward to being part of the exhibition area and holding the following sessions: \n\nMultiple Sclerosis (MS) and Amyotrophic Lateral Sclerosis (ALS): advancing clinical decision making through wearables\, poster presentation\nAssessing the Digital Care Pathways Unmet Needs for Rare Brain Diseases. The Case of Phenylketonuria\, poster presentation\, 2 July\, 12:52\nToward a European Brain Health Plan\, EAN TV Studio Session\, 29 June 2024\, 11:30-12:30\nDigital Care Pathways for Rare Brain Diseases. The Case of Phenylketonuria\, Scientific Theatre\, 30 June 2024\, 12:15-12:45\nEBC: Towards the European Partnership on Brain Health\, Scientific Theatre\, 30 June 2024\, 15:45-16:15\nUniting Multiple Sclerosis and Amyotrophic Lateral Sclerosis Research Innovations through Collaborative Endeavours\, Scientific Theatre\, 1 July 2024\, 14:05-14:35\n\nFor more information about EAN 2024 – including programme – please explore the congress website! \nFind out more!
URL:https://www.braincouncil.eu/event/10th-congress-of-the-european-academy-of-neurology/
ATTACH;FMTTYPE=image/jpeg:https://www.braincouncil.eu/wp-content/uploads/2023/11/EAN-2024-Helsinki-banner-1820-x-300.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240629
DTEND;VALUE=DATE:20240703
DTSTAMP:20260415T194746
CREATED:20240318T140010Z
LAST-MODIFIED:20240611T111818Z
UID:53646-1719619200-1719964799@www.braincouncil.eu
SUMMARY:Multiple Sclerosis (MS) and Amyotrophic Lateral Sclerosis (ALS): advancing clinical decision making through wearables | 10th Congress of the EAN
DESCRIPTION:EBC is pleased to hold a poster presentation "Multiple Sclerosis (MS) and Amyotrophic Lateral Sclerosis (ALS): advancing clinical decision making through wearables" at the upcoming 10th Congress of the European Academy of Neurology. The Conference will take place from 29 June until 2 July April 2024 in Helsinki (Finland). \nPoster will represent the BRAINTEASER project. \nBRAINTEASER is a Horizon 2020-funded project harnessing the value of big data to develop AI-based solutions for people with MS and ALS. As a project partner\, the European Brain Council currently leads liaison activities with relevant European (EU) and global projects and initiatives with the aim of identifying key priorities in the field and speaking with one voice to foster evidence-based policymaking and improve EU healthcare systems. \nAuthors: D. Faye\, K. Aarts\, S. Kramer\, F. Destrebecq  \nLEARN MORE ABOUT BRAINTEASER PROJECTLEARN MORE ABOUT EBC AT EAN CONGRESS
URL:https://www.braincouncil.eu/event/multiple-sclerosis-ms-and-amyotrophic-lateral-sclerosis-als-advancing-clinical-decision-making-through-wearables-10th-congress-of-the-ean/
LOCATION:Helsinki\, Finland
ATTACH;FMTTYPE=image/jpeg:https://www.braincouncil.eu/wp-content/uploads/2024/02/1920-x-600.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20240629T113000
DTEND;TZID=UTC:20240629T123000
DTSTAMP:20260415T194747
CREATED:20240517T112237Z
LAST-MODIFIED:20240627T085725Z
UID:54141-1719660600-1719664200@www.braincouncil.eu
SUMMARY:Towards a European Brain Health Plan | 10th Congress of the European Academy of Neurology
DESCRIPTION:Date and time: Monday\, 29.06.2024\, 11:30-12:30 \nLocation: EAN TV \n2024 is a pivotal year for brain health\, research\, and innovation\, particularly at the policy level. 64 countries across the globe will exercise the right to vote across this year\, EU Elections included. As we enter new governmental mandates across the continent\, it is more important than ever to push the brain health agenda to the top of policy priority lists and reach the key decision makers to showcase just how important addressing and attending to the brain really is.  \nBrain disorders – encompassing neurological diseases and disorders and mental illnesses – are widespread\, disabling\, and difficult to treat. In fact\, it is estimated that up to three billion people worldwide live with a neurological condition and 970 million people around the world were living with a mental health disorder as of 2019. These conditions represent a high individual\, social and economic burden and contribute immensely to the global burden of disease – in fact\, as of 2024\, neurological conditions alone are now the leading cause of ill health and disability worldwide.  \nWith this growing burden in mind\, we need to not only find ways to address the ongoing issues but to work towards a society fully recognizing the potential of supporting citizens' brain health. At its best\, optimal brain health allows people to thrive: to live in health and in happiness\, to power our labour markets and economies\, and to build for future generations. Instead of divesting in a cost\, policymakers and society at large should view the prioritization and support of brain health\, research\, and innovation as an investment into prevention\, wellness\, and optimization\, creating a better future for every citizen.  \nThis session will bring together key voices from the brain community – clinicians\, patients and political scientists – to discuss the work being done at the national and regional levels to advocate for brain health\, exploring the challenges and sharing the achievements thus far.   \nSpeakersStephanie KramerAstri ArnesenProf. Claudio BassettiLecture Title: Establishing a National Brain Health Plan: Lessons Learned From Switzerland \nLecture Title: Patient-centred brain health strategies \nLecture Title: Establishing a National Brain Health Plan: Lessons Learned From Switzerland \nStephanie Kramer joined EBC in March 2016 within the projects team\, eventually making the move to heading the Communications\, Advocacy & Policy team until 2023. Aside from the day to day\, Stephanie’s role as Deputy Director continues to oversee the Communications & Advocacy work\, with a more strategic role focused on EBC’s global partnerships portfolio\, external relations and larger-scale advocacy events. \nStephanie holds an LLM in International Law from the University of Edinburgh\, and a BA in International Relations & Diplomacy from Schiller International University Heidelberg & Madrid. An expat since childhood\, before starting her career in the Brussels bubble she had previous communications\, external relations and project management experience at the United Nations headquarters in Vienna and private sector companies in the Netherlands and Chile. \nAstri has been a patient representative and advocate since the mid-1980s. She served as President of the Norwegian Huntington Association from 2004-2014\, joined the board of the European Huntington Association (EHA) in 2010\, and was elected President in 2016. Currently\, she works full time for EHA. Previously\, she was head of a department providing expertise in special educational needs. Astri is a trained teacher in learning disabilities with additional degrees in developmental psychology\, management\, and innovative processes. She has a broad network within the HD community globally and is active in the rare disease field through Eurordis and the European Reference Networks (ERN)\, also serving on the steering committee for ePAGs (patient reps in ERNs). \nProfessor Claudio Bassetti has been full professor and chair of neurology at the University Hospital in Bern since 2012. He received his medical degree in Basel and trained in neurology in Bern and Lausanne. In 2000\, he became professor and vice-chair of neurology in Zurich. In 2009 he founded the Neurocenter of Southern Switzerland. He completed his research fellowships in basic neurophysiology in Basel and sleep in Ann Arbor\, Boston and Madison. His major scientific interests are the relationship between sleep and neurological disorders\, narcolepsy\, and the teaching of general neurology. He uses clinical and experimental approaches and has published more than 500 articles and eight books. Prof. Bassetti has previously served as president of the European Neurological Society\, European Sleep Research Society and Swiss Neurological Society\, and founded the Swiss Federation of Clinical Neurosocieties. He is an elected member of the Swiss Academy of Medical Sciences\, which he served as board member for eight years. He has been president of the European Academy of Neurology since 2020 and was appointed Dean of the Medical Faculty in Bern that same year. \nLEARN MORE ABOUT EBC AT EAN CONGRESS
URL:https://www.braincouncil.eu/event/towards-a-european-brain-health-plan-10th-congress-of-the-european-academy-of-neurology/
LOCATION:Helsinki\, Finland
ATTACH;FMTTYPE=image/jpeg:https://www.braincouncil.eu/wp-content/uploads/2024/02/1920-x-600.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20240630T121500
DTEND;TZID=UTC:20240630T124500
DTSTAMP:20260415T194747
CREATED:20240517T101446Z
LAST-MODIFIED:20240627T090641Z
UID:54136-1719749700-1719751500@www.braincouncil.eu
SUMMARY:Digital Care Pathways for Rare Brain Diseases\, The Case of Phenylketonuria | 10th Congress of the European Academy of Neurology
DESCRIPTION:Date and time: Sunday\, 30.06.2024\, 12:15-12:45 \nLocation: Scientific Theatre \nThe session will introduce the audience to the European Brain Council (EBC) and its activities on health services research and the value of education\, digital care pathways for rare brain diseases. \nThe opportunities offered by data and digital health are multiplying. While barriers remain to unlocking their full potential\, we are at an unprecedented moment of change. The European Health Data Space and the AI Act hold the promise of shaping a digital ecosystem that can accelerate the shift towards patient-centred\, outcomes-focused\, and sustainable healthcare in Europe\, and improve patient safety and reduce avoidable harm. Patient care is undergoing a significant transformation\, and three key factors – data\, patient education and inclusivity – are at the forefront of this change. To gain a deeper understanding of these trends\, we examined both patient and provider views. These insights offer a glimpse into the future of patient care. Digital Care Pathways for Rare Brain Diseases research project (2023-2024) – The Case of Phenylketonuria is coordinated by the European Brain Council. The Covid-19 pandemic accelerated the healthcare sector’s digital transformation agenda. The delivery of telemedicine services instead of many face-to-face procedures has been expanded and many healthcare services shifted online remotely. The study is looking at the unmet needs of patients related to information\, education and communication in the management and monitoring of Phenylketonuria (PKU) along the digital care pathways. We collected data from patients and caregivers in Ireland\, Germany and Spain using a patient survey that was co-designed with PKU patient associations\, to gather information about where and how can digital tools support PKU diagnosis\, treatment and follow-up. While looking at the patient perspective\, the clinician perspective is equally important. This project examines further what is the current state of digital transformation within healthcare systems and how to address the fundamental challenges that hinder the acceleration of the data-driven revolution. \nSpeakersVinciane QuoidbachLecture Title: European Brain Council: Value of education\, digital care pathways for rare brain diseases. \nVinciane Quoidbach is Research Project Manager – Public Health and Policy for the Value of Treatment for Brain Disorders Study at the European Brain Council. Vinciane holds a Master Degree in Hospital and Healthcare Management from Solvay Brussels School of Economics and Management and a Postgraduate Diploma in Public Health Management from Manchester Business School. She also holds a Master Degree in Political Sciences and European Studies from University of Antwerp. Prior to this position\, Vinciane worked in both public and private sector\, at national and international level. She served the Belgian Federal Public Service Health\, and the Federal Minister of Health Cabinet as Advisor in charge of public health policy and regulations development in the area of Cancer\, Chronic Diseases and Rare Diseases as well as the Biopharmaceutical Company AbbVie as Health Initiatives Manager. \nBernadette Sheehan Gilroy Lecture Title: Can digital tools support care pathways for rare brain diseases? The case of Phenylketonuria \nBernadette Sheehan Gilroy is a Lecturer at Munster Technological University (MTU) Ireland\, a PKU Researcher\, Advocate and a graduate of the IPPOSI Patient Education Programme. Bernadette recently delivered a TEDx Talk on “The Empowering Role of Advocacy – A Parent’s Perspective” to broaden understanding and compassion around PKU. She is a MTU representative on the All Ireland Rare Disease Interdisciplinary Research Network. She has spoken at Irish and European Parliamentary events\, co-led the development of a care pathway for PKU\, and has been a PKU patient representative in the Health Technology Assessment process for access to medicines with the National Centre for Pharmacoeconomics. She has been involved in many campaigns to raise awareness of the unmet needs and significant challenges of the PKU and Rare Disease communities to improve patient and family experience. PKU\, is a rare neurometabolic disorder that affects a person’s ability to metabolise protein and if left untreated can lead to devastating neurological complications. \nLEARN MORE ABOUT THE VALUE OF TREATMENTLEARN MORE ABOUT EBC AT EAN CONGRESS
URL:https://www.braincouncil.eu/event/digital-care-pathways-for-rare-brain-diseases-the-case-of-phenylketonuria-10th-congress-of-the-european-academy-of-neurology/
LOCATION:Helsinki\, Finland
ATTACH;FMTTYPE=image/jpeg:https://www.braincouncil.eu/wp-content/uploads/2024/02/1920-x-600.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Moscow:20240630T154500
DTEND;TZID=Europe/Moscow:20240630T161500
DTSTAMP:20260415T194747
CREATED:20240523T102806Z
LAST-MODIFIED:20240611T112556Z
UID:54167-1719762300-1719764100@www.braincouncil.eu
SUMMARY:EBC: Towards the European Partnership on Brain Health
DESCRIPTION:Neurological and mental health disorders are a leading cause of mortality and disability putting a great burden on people living with these disorders as well as on healthcare systems and economies. Considering the costs of brain diseases for the European society\, the EU and its Member States have made investments in brain research leading to an increase of initiatives. Those initiatives have generated considerable amounts of knowledge but the translation into new health interventions is hindered by the complexity of the challenge and by excessive fragmentation of the efforts. \nEffective and efficient collaboration and cooperation among the various initiatives are often identified as a key success factor to achieve brain research full impact. There is a constant need for strengthening the information flow and accelerating the exchange of experience on the on-going and future projects as well as maintaining continuous dialogue between all the stakeholder groups and initiatives to allow that objectives are aligned\, and needs are met. \nThe European Partnership on Brain Health will fully respond to these needs by bringing together the various stakeholders and major brain research initiatives. With the aim to further coordinate and structure the area of brain health research in Europe\, the partners in the Coordination and Support Action (CSA) Brain Health developed an ambitious Strategic Research and Innovation Agenda\, outlining the strategic priorities\, actions\, and initiatives\, while encouraging maximum engagement of member states and relevant players in the brain field – including psychiatrists and people living with brain disorders. \nDuring this scientific theatre\, an introduction to the European Brain Council and the CSA Brain Health will be given and we will focus deeper on the development process and content of the Strategic Research and Innovation Agenda. \nSpeakerKristien AartsKristien has been part of the European Brain Council since 2019 where she currently leads the research team. In the Chief Research & Innovation Officer strategic role\, Kristien plays a pivotal role in ensuring that the organization’s work is grounded in scientific evidence\, research\, and innovation. \nHer responsibilities include monitoring research funding\, project applications\, overseeing EU-funded projects\, and developing a rare brain disease ecosystem. She also manages the Brain Innovation Days program and is actively creating an evidence-based brain health toolbox for the team. \nKristien has a PhD in Psychology from Ghent University (Belgium). With diverse experience at Lyon Neuroscience Research Center\, the European Health Management Association and the University of Utrecht\, Kristien brings expertise in brain research\, neuropsychology\, emotion\, cognition\, multisensory processing\, mindfulness\, clinical research management\, and EU-project management. \nLEARN MORE ABOUT Coordination and Support Action BrainHealthLEARN MORE ABOUT EBC AT EAN CONGRESS
URL:https://www.braincouncil.eu/event/ebc-towards-the-european-partnership-on-brain-health/
ATTACH;FMTTYPE=image/jpeg:https://www.braincouncil.eu/wp-content/uploads/2023/11/EAN-2024-Helsinki-banner-1820-x-300.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20240701T140500
DTEND;TZID=UTC:20240701T143500
DTSTAMP:20260415T194747
CREATED:20240517T103225Z
LAST-MODIFIED:20240611T111727Z
UID:54137-1719842700-1719844500@www.braincouncil.eu
SUMMARY:EBC: Uniting Multiple Sclerosis and Amyotrophic Lateral Sclerosis Research Innovations through Collaborative Endeavors | 10th Congress of the European Academy of Neurology
DESCRIPTION:Date and time: Monday\, 01.07.2024\, 14:05-14:35 \nLocation: Scientific Theatre \nThe session will introduce the audience to the European Brain Council (EBC) and its activities. As a network of key stakeholders in the EU brain space including neurologists\, psychiatrists and neurosurgeons\, neuroscientists\, neurological and mental patient advocates and industry partners\, EBC aims to foster collaboration in brain health\, research and innovation\, promote the translation of research breakthroughs in the clinical practice and bridge the gap between scientists and EU policymakers. EBC also deploys his mission by gathering the EU brain community at its annual event\, Brain Innovation Days\, and through its involvement in EU-funded research projects including BRAINTEASER – Bringing artificial intelligence home for a better care of amyotrophic lateral sclerosis and multiple sclerosis. BRAINTEASER exploits the value of AI and big data to advance remote monitoring and clinical decision making in Multiple Sclerosis and Amyotrophic Lateral Sclerosis. The audience will have a glimpse of BRAINTEASER clinical tool and models in the second presentation. The second speaker will also discuss some preliminary results. \nSpeakersDieyenaba FayeLecture Title: European Brain Council: Uniting MS and ALS Research Innovations through Collaborative Endeavours \nDieyenaba joined EBC in March 2023. As Project Officer\, she mainly supports the application for prospective EU projects and the delivery of ongoing ones. Within the EBC Value of Treatment initiative\, she also coordinates the case study on Chronic Pain disorders. \nDieyenaba has a biomedicine background focused on human nutrition. Through a science page\, she popularises nutrition science promoting healthier food and lifestyle choices. Her interests include nutritional neuroscience and healthy ageing. \nDuring her time at the European Pain Federation EFIC\, Dieyenaba also gained experience in communications and advocacy at the EU level. \nUmberto ManeraLecture Title:Bringing Artificial Intelligence home for a better care of ALS and MS: the BRAINTEASER Project \nUmberto Manera is Assistant Professor and Neurologist at the “Rita Levi Montalcini” Department of Neuroscience of the University of Turin and the Neurology Unit of “Città della Salute e della Scienza di Torino”. He has been working at the ALS Center in Turin since 2010. He mainly deals with clinical research on ALS. His scientific activity includes several topics\, including neuroepidemiology\, the evaluation of disease phenotypes and respiratory function assessment measures\, biomarkers\, neuroimaging. He also works as a sub-investigator for various randomized clinical trials. He is currently co-author of more than 110 scientific articles published in international peer-reviewed journals. \nLEARN MORE ABOUT BRAINTEASER PROJECTLEARN MORE ABOUT EBC AT EAN CONGRESS
URL:https://www.braincouncil.eu/event/ebc-uniting-multiple-sclerosis-and-amyotrophic-lateral-sclerosis-research-innovations-through-collaborative-endeavors-10th-congress-of-the-european-academy-of-neurology/
LOCATION:Helsinki\, Finland
ATTACH;FMTTYPE=image/jpeg:https://www.braincouncil.eu/wp-content/uploads/2024/02/1920-x-600.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20240702T125200
DTEND;TZID=UTC:20240702T125500
DTSTAMP:20260415T194747
CREATED:20240318T140951Z
LAST-MODIFIED:20240611T112115Z
UID:53649-1719924720-1719924900@www.braincouncil.eu
SUMMARY:Assessing the Digital Care Pathways Unmet Needs for Rare Brain Diseases. The Case of Phenylketonuria | 10th Congress of the EAN
DESCRIPTION:EBC is pleased to hold a poster presentation "Assessing the Digital Care Pathways Unmet Needs for Rare Brain Diseases. The Case of Phenylketonuria" at the upcoming 10th Congress of European Academy of Neurology. The Conference will take place from 29 June until 2 July-26 2024 in Helsinki (Finland). The poster will be presented by Vinciane Quoidbach\, Research Project Manager in Public Health and Policy for Value of Treatment for Brain Disorders Study at EBC\, and one of the experts involved in the Value of Education project. \nPoster will represent the part of Value of Education project. \nDigital Care Pathways for Rare Brain Diseases research project (2023-2024) is coordinated by the European Brain Council. The study is looking at the unmet needs while using digital care pathways and aiming to assess the benefits of health digital tools from the patient' perspective after COVID-19 pandemic\, presenting the phenylketonuria (PKU) case study. \nAuthors: Cannizzo S\, Quoidbach V\, Treacy EP\, Hermida A\, MacDonald A\, Scarpa M\, Van Spronsen F\, Lange E\, Sheehan-Gilroy B\, Hagedorn T\, Bak A\, Turchetti G   \nLEARN MORE ABOUT THE VALUE OF TREATMENTLEARN MORE ABOUT EBC AT EAN CONGRESS
URL:https://www.braincouncil.eu/event/assessing-the-digital-care-pathways-unmet-needs-for-rare-brain-diseases-the-case-of-phenylketonuria-the-10th-congress-of-ean/
LOCATION:Helsinki\, Finland
ATTACH;FMTTYPE=image/jpeg:https://www.braincouncil.eu/wp-content/uploads/2024/02/1920-x-600.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240805
DTEND;VALUE=DATE:20240810
DTSTAMP:20260415T194747
CREATED:20240409T064209Z
LAST-MODIFIED:20240409T120736Z
UID:53838-1722816000-1723247999@www.braincouncil.eu
SUMMARY:IASP 2024 World Congress on Pain
DESCRIPTION:About IASP 2024 World Congress on PainIASP's World Congress on Pain is the largest gathering of pain professionals in the world\, bringing together more than 5\,000 scientists\, clinicians\, and healthcare providers from around the world and across pain disciplines. Attendees will experience a world-class lineup of more than 400 international speakers with comprehensive sessions bringing you the latest pain research and treatment. \nThe World Congress will include the IASP 50th Anniversary celebration with reflections on industry advances in pain research and IASP milestones over the last 50 years. Join IASP 5 – 9 August 2024 in Amsterdam to commemorate 50 years of working together for pain relief throughout the World. \nEBC will attend the Congress and will hold 3 poster presentation: \n\nHealth Gains and Socio-Economic Impacts of Multimodal Management of Diabetic Neuropathic Pain\nHealth Gains and Socio-Economic Impacts of Structured Interdisciplinary Management of Fibromyalgia Syndrome\nHealth Gains and Socio-Economic Impacts of Structured Interdisciplinary Management of Chronic Primary Low-Back Pain\n\nLEARN MORE AND REGISTER
URL:https://www.braincouncil.eu/event/iasp-2024-world-congress-on-pain/
LOCATION:Amsterdam\, The Netherlands
ATTACH;FMTTYPE=image/webp:https://www.braincouncil.eu/wp-content/uploads/2024/04/59ec1c1b87924a04983b63473d58d524_c6dd498835f30c6fce901dccefa94388.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20240806T093000
DTEND;TZID=UTC:20240806T110000
DTSTAMP:20260415T194747
CREATED:20240409T065516Z
LAST-MODIFIED:20240730T120838Z
UID:53842-1722936600-1722942000@www.braincouncil.eu
SUMMARY:Health Gains and Socio-Economic Impacts of Multimodal Management of Diabetic Neuropathic Pain | IASP 2024 World Congress on Pain
DESCRIPTION:About the poster presentationEBC will hold a poster presentation at IASP 2024 World Congress on Pain on the topic “Health Gains and Socio-Economic Impacts of Multimodal Management of Diabetic Neuropathic Pain”. \nDiabetic neuropathic pain is one of the largest health burdens in countries around the globe. Pain specialists had developed a multimodal approach to chronic pain management in the 1980ies that leads to major improvements in functioning and quality of life and reduced work absenteeism. Multimodal pain management is offered by specialized clinics in some countries\, but is not generally available to the patient population at large. This is partly due to the consideration that it may be too expensive. Led by the European Brain Council within the Value of Treatment (VoT) initiative\, VoT Chronic Pain analysed to what extent the cost of multimodal management is offset by savings in direct and indirect cost of continuing the current standard of care.   \nThe aim of this study is to assess the cost-effectiveness of chronic pain management in one model country (Germany) with and without multimodal treatment in patients with diabetic neuropathic pain.  \nCome and participate in the IASP 2024 World Congress on Pain to delve into the findings of the study and interact with experts face-to-face to ask your questions! \nSpeakerMark Nuijten \nMark Nuijten\, PhD\, MD\, MBA\, is an Adjunct Professor at ITU\, a medical doctor\, health economist\, market access and pricing consultant\, valuation economist\, and healthcare policy journalist. He has a diverse career in the health academic and business environment\, collaborating with leading experts in health economics. \nNuijten is developing economic modelling in healthcare and finance. He’s a pioneer in healthcare innovation in biotechnology and nutrition\, and the first to apply and develop Discounted Cash Flow methodologies for biotechnology innovation valuation. His innovative concepts include the Pricing Matrix Model for early phase pricing and the Financial Valuation Algorithm for assessing future cash flows of new medicinal products. His reimbursement dossiers have contributed to positive reimbursement decisions by health authorities in many countries. \nHe supervises PhD programs at the Universities of Maastricht and Groningen in The Netherlands and is the founder of the ISPOR Special Interest Group on nutrition-economics. He is also an Adjunct Professor at ITU (Istanbul Technical University) in International Healthcare Assessment and Valuation. \nNuijten is a founding member of Minerva Health Economics Network\, Ltd. (MINERVA)\, an affiliation of independent health-economic consultancies and contract-research organizations. Before setting up A2M\, he was a partner with EVIDERA\, establishing global Pricing and Reimbursement Consultancy Services\, and was Managing Director of the IQVIA office in the Netherlands. \nNuijten trained as a physician before obtaining an international MBA from Erasmus University\, Rotterdam\, and a PhD in health economics. He has become a leading health economic expert\, with over 200 publications and leading positions in scientific societies and editorial boards. He was on the Board of Directors of ISPOR (2002-2004) and contributed to the first Dutch pharmaco-economic research guidelines and costing manual. \nLEARN MORE ABOUT VOT CHRONIC PAINLEARN MORE ABOUT THE CONGRESS
URL:https://www.braincouncil.eu/event/health-gains-and-socio-economic-impacts-of-multimodal-management-of-diabetic-neuropathic-pain-iasp-2024-world-congress-on-pain/
LOCATION:Amsterdam\, The Netherlands
ATTACH;FMTTYPE=image/webp:https://www.braincouncil.eu/wp-content/uploads/2024/04/59ec1c1b87924a04983b63473d58d524_c6dd498835f30c6fce901dccefa94388.webp
END:VEVENT
END:VCALENDAR